To understand the underlying mechanism of NAT10 on regulating ac4C modification in DLBCL, mRNA‐seq and acRIP‐seq were conducted, and SLC30A9 was found as an intermediate target. Here, NAT10 is linked to diffuse large B-cell lymphoma.